otten-lifesciences-consulting
  • HOME
  • SERVICES
  • SUCCESS
  • ABOUT
  • NEWS
  • CONTACT
Select Page
  • HOME
  • SERVICES
  • SUCCESS
  • ABOUT
  • NEWS
  • CONTACT

Dr. Thierry Fumeaux, as new CEO at Acthera

Acthera has appointed Thierry Fumeaux as CEO beginning February 2022. He started in April 2021 as the company’s Chief Medical Officer, and Co-CEO in September 2021. Pierre-Alain Monnard will be the CSO (Chief Science Officer) of the Company.

…

Read more > acthera-therapeutics.com , Thierry Fumeaux’s LinkedIn

Recent Posts

  • NETRIS Pharma Announces Positive Interim Phase II Results for NP137 in combination with anti-PD(L)1
  • Is there an age limit for launching your first startup? Is 50 “too old” to become a founder ?
  • TheraPPI completes a first closing of Pre-Seed Financing to advance its lead oncology program targeting a novel protein interaction
  • NETRIS Pharma Welcomes Eric Falcand as Independent Director to Its Board of Directors
  • NETRIS Pharma Announces FDA Orphan Drug Designation (ODD) for NP137 in Pancreatic Cancer Treatment
© 2025 Otten Life Sciences Consulting. All Rights Reserved / Image sources: dreamstime and proprietary